HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sally L Dunwoodie Selected Research

Jarcho-Levin syndrome

3/2011Notch inhibition by the ligand DELTA-LIKE 3 defines the mechanism of abnormal vertebral segmentation in spondylocostal dysostosis.
1/2008Role of Delta-like-3 in mammalian somitogenesis and vertebral column formation.
6/2004Dll3 pudgy mutation differentially disrupts dynamic expression of somite genes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sally L Dunwoodie Research Topics

Disease

8Hypoxia (Hypoxemia)
01/2020 - 10/2007
3Jarcho-Levin syndrome
03/2011 - 06/2004
2Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2021
2Inflammation (Inflammations)
01/2021 - 01/2020
2Congenital Abnormalities (Deformity)
01/2020 - 01/2020
2Congenital Heart Defects (Congenital Heart Defect)
01/2020 - 05/2005
1Schizophrenia (Dementia Praecox)
11/2021
1Habitual Abortion (Recurrent Miscarriage)
11/2021
1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell)
01/2020
1Embryo Loss
01/2020
1Spontaneous Abortion (Miscarriage)
01/2020
1Ischemic Stroke
01/2019
1Stroke (Strokes)
01/2019
1Coronary Artery Disease (Coronary Atherosclerosis)
01/2019
1Vascular Diseases (Vascular Disease)
01/2019
1Intellectual Disability (Idiocy)
12/2017
1Obesity
12/2016
1Type 2 Diabetes Mellitus (MODY)
12/2016
1Blindness (Hysterical Blindness)
10/2009
1Corneal Neovascularization
10/2009
1Cardiomyopathies (Cardiomyopathy)
05/2005

Drug/Important Bio-Agent (IBA)

5Transcription Factors (Transcription Factor)IBA
01/2020 - 05/2005
4Oxygen (Dioxygen)IBA
01/2020 - 12/2009
3NAD (NADH)IBA
11/2021 - 01/2020
3Trans-Activators (Trans-Acting Factor)IBA
01/2021 - 12/2016
3LigandsIBA
03/2011 - 06/2004
2Aspartic Acid (Aspartate)FDA Link
01/2021 - 01/2020
2Biological ProductsIBA
01/2021 - 10/2007
2Glutamic Acid (Glutamate)FDA Link
01/2021 - 01/2020
2CytokinesIBA
01/2020 - 10/2007
2Proteins (Proteins, Gene)FDA Link
01/2019 - 07/2014
1AntioxidantsIBA
01/2022
1Pharmaceutical PreparationsIBA
01/2020
1Anti-Arrhythmia AgentsIBA
01/2020
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2019
1Endothelin-1 (Endothelin 1)IBA
01/2019
1Co-Repressor ProteinsIBA
01/2019
1Homeodomain Proteins (Proteins, Homeobox)IBA
12/2017
1Insulin (Novolin)FDA Link
12/2016
1CateninsIBA
05/2015
1ElementsIBA
07/2014
1Glucose (Dextrose)FDA LinkGeneric
01/2014
1Differentiation AntigensIBA
01/2014
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2012
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2007
1LipopolysaccharidesIBA
10/2007
1N-acetyltalosaminuronic acid (NAT)IBA
06/2004

Therapy/Procedure

2Therapeutics
01/2022 - 10/2009
1Precision Medicine
01/2021
1Debridement
10/2009